Contact +32 16 34 48 00 - appointments Contact form Address UZ Leuven gasthuisberg campusNeurologyHerestraat 493000 LeuvenDirections and services News and events First successful treatment of ALS in patients with SOD1 mutation 22 September 2022 A new international clinical trial with tofersen confirms that the drug can stop ALS in patients with a SOD1 mutation. With this doctors and researchers show for the first time that, in principle, ALS is a treatable disease. The results have been published in NEJM. Ophthalmologists, biologists and engineers wage war on Alzheimer's 26 May 2021 Researchers at UZ Leuven, KU Leuven, VITO and imec have published promising results on the use of a hyperspectral camera to detect protein plaques in the eyes of Alzheimer's patients. Early detection of ALS and frontotemporal dementia 3 June 2020 A PET-MR brain scan can detect early changes in people with an increased risk of developing ALS or frontotemporal dementia as a result of a genetic error, as discovered by VIB, KU Leuven and UZ Leuven researchers. Last edit: 18 January 2023